ATE334202T1 - Plasmide, deren konstruktion und deren verwendung zur herstellung von interleukin-4 und interleukin-4 muteine - Google Patents

Plasmide, deren konstruktion und deren verwendung zur herstellung von interleukin-4 und interleukin-4 muteine

Info

Publication number
ATE334202T1
ATE334202T1 AT00100129T AT00100129T ATE334202T1 AT E334202 T1 ATE334202 T1 AT E334202T1 AT 00100129 T AT00100129 T AT 00100129T AT 00100129 T AT00100129 T AT 00100129T AT E334202 T1 ATE334202 T1 AT E334202T1
Authority
AT
Austria
Prior art keywords
interleukin
muteins
construction
plasmids
producing
Prior art date
Application number
AT00100129T
Other languages
English (en)
Inventor
Heiner Dr Apeler
Hermann Dr Wehlmann
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Application granted granted Critical
Publication of ATE334202T1 publication Critical patent/ATE334202T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/72—Expression systems using regulatory sequences derived from the lac-operon

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00100129T 1999-01-20 2000-01-07 Plasmide, deren konstruktion und deren verwendung zur herstellung von interleukin-4 und interleukin-4 muteine ATE334202T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99100967A EP1022339B1 (de) 1999-01-20 1999-01-20 Plasmide, deren Konstruktion und Anwendung zur Herstellung von Interleukin-4 und dessen Muteine

Publications (1)

Publication Number Publication Date
ATE334202T1 true ATE334202T1 (de) 2006-08-15

Family

ID=8237378

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00100129T ATE334202T1 (de) 1999-01-20 2000-01-07 Plasmide, deren konstruktion und deren verwendung zur herstellung von interleukin-4 und interleukin-4 muteine

Country Status (15)

Country Link
US (1) US6506590B1 (de)
EP (1) EP1022339B1 (de)
JP (2) JP2000210091A (de)
KR (1) KR100665148B1 (de)
AT (1) ATE334202T1 (de)
AU (1) AU772897B2 (de)
CA (1) CA2294575C (de)
CZ (1) CZ294279B6 (de)
DE (1) DE69929638T2 (de)
DK (1) DK1022337T3 (de)
ES (1) ES2269027T3 (de)
HU (1) HU224491B1 (de)
NO (1) NO327317B1 (de)
PT (1) PT1022337E (de)
SK (1) SK285603B6 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10022258A1 (de) 2000-05-08 2001-11-15 Bayer Ag Reinigung von Proteineinschlusskörpern durch Querstrom-Mikrofiltration
KR100443570B1 (ko) * 2001-07-31 2004-08-09 크레아젠 주식회사 재조합 인간 인터루킨-4의 제조방법
EP1314739A1 (de) 2001-11-22 2003-05-28 Bayer Ag Verfahren zur Renaturierung rekombinanter, Disulfid-enthaltender Proteine bei hohen Proteinkonzentrationen in Gegenwart von Aminen
JP2006055082A (ja) * 2004-08-20 2006-03-02 National Institute Of Advanced Industrial & Technology 発光甲虫由来赤色発光酵素安定体の生産及び精製法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689406A (en) * 1983-08-10 1987-08-25 Amgen Enhancement of microbial expression of polypeptides
AU597951B2 (en) * 1986-03-27 1990-06-14 Monsanto Company Enhanced protein production in bacteria by employing a novel ribosome binding site
EP0303925B1 (de) * 1987-08-17 1995-06-07 F. Hoffmann-La Roche Ag Hochreprimierbare Expressionskontrollsequenzen
FR2724665B1 (fr) * 1994-09-16 1996-12-20 Rhone Poulenc Rorer Sa Procede de production de proteines recombinantes, plasmides et cellules modifiees
MY124565A (en) * 1996-07-19 2006-06-30 Bayer Corp High-affinity interleukin-4-muteins

Also Published As

Publication number Publication date
KR20000053523A (ko) 2000-08-25
US6506590B1 (en) 2003-01-14
HU224491B1 (hu) 2005-09-28
JP2010284174A (ja) 2010-12-24
JP2000210091A (ja) 2000-08-02
SK285603B6 (sk) 2007-04-05
CA2294575C (en) 2009-04-07
ES2269027T3 (es) 2007-04-01
EP1022339B1 (de) 2006-02-01
NO20000262L (no) 2000-07-21
CZ294279B6 (cs) 2004-11-10
KR100665148B1 (ko) 2007-01-09
DK1022337T3 (da) 2006-11-06
EP1022339A1 (de) 2000-07-26
CZ2000214A3 (cs) 2000-08-16
DE69929638T2 (de) 2006-09-21
HU0000185D0 (en) 2000-04-28
AU772897B2 (en) 2004-05-13
HUP0000185A2 (en) 2002-09-28
AU1250700A (en) 2000-07-27
CA2294575A1 (en) 2000-07-20
PT1022337E (pt) 2006-11-30
NO20000262D0 (no) 2000-01-19
SK762000A3 (en) 2000-08-14
NO327317B1 (no) 2009-06-08
DE69929638D1 (de) 2006-04-13

Similar Documents

Publication Publication Date Title
DE60233029D1 (de) "hyperblebbing" bakterielle stämme und ihre verwendung zur herstellung von impfstoffen
ATA189691A (de) Hpth-peptide, ihre herstellung und verwendung
ATE383424T1 (de) Polypeptide, deren herstellung und verwendung
DE60038200D1 (de) ren Herstellung und Verwendung
ATE443719T1 (de) Interleukin-18 bindende proteine, deren herstellung und verwendung
ATE551363T1 (de) Verwendung von antikörper gegen interleukin-4 rezeptor und deren zusammensetzungen
DE60235547D1 (de) En daraus, deren herstellung und verwendung
ATE71144T1 (de) Gm-csf-protein, seine derivate, herstellung solcher proteine und ihre verwendung.
DE69841063D1 (de) Disulfid-vernetzte Glycoprotein-Hormone, ihre Herstellung und Verwendung
DE60218807D1 (de) Rutheniumkomplexe und deren Verwendung zur Herstellung von Alkoholen
DE69808266D1 (de) Herstellung und verwendung von alpha-ketoamid derivate und anordnunge
ATE364090T1 (de) Parapockenviren, die fremd-dna enthalten, ihre herstellung und ihre verwendung in impfstoffen
ATE431363T1 (de) Modifizierte faktor viii cdna und ihre verwendung zur produktion von faktor viii
DE60212425D1 (de) Fsh-zusammensetzungen mit hohem sialylierungsgrad und deren verwendung zur herstellung von arzneimitteln
DE69532485D1 (de) Trehalose-freisetzendes Enzym, dafür kodierende DNA, Herstellung und Verwendung
DE69815866D1 (de) Verwendung von shogaolen und gingerolen zur herstellung von deodoranzien
ATE73462T1 (de) Hirudin-variante, deren verwendung und herstellung.
ATE334202T1 (de) Plasmide, deren konstruktion und deren verwendung zur herstellung von interleukin-4 und interleukin-4 muteine
DE50209948D1 (de) Verwendung von Scopinester Derivaten zur Herstellung von Arzneimitteln
DE69421743T2 (de) Silikongummi-Zusammensetzungen, Herstellung und Verwendung
ATE286509T1 (de) Interferon alpha/beta bindendes protein, seine herstellung und anwendung
DE60238810D1 (de) Rekombinante D-Hydantoin Hydrolasen und N-Carbamyl-Aminosäure Amid Hydrolasen, dafür kodierende DNA; deren Verwendung zur Herstellung von D-Aminosäuren
DE69722411D1 (de) Katalytische zusammensetzung, deren herstellung, und deren verwendung zur katalytischen verbrennung
CY1105277T1 (el) Πλασμιδια, κατασκευη αυτων και χρηση αυτων στη βιομηχανικη κατασκευη ιντepλευκινης -4 και μεταλλαξινων ιντepλευκινης-4
DE59106119D1 (de) Stabilisatorkombinationen und ihre Verwendung zur Herstellung von stabilisierten, schlagzähmodifizierten Polyamiden.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1022337

Country of ref document: EP

EEIH Change in the person of patent owner